S22-525 P-Selectin Inhibition as a Treatment for Lymphedema The Nicolls Lab at Stanford University has discovered P-selectin inhibitors as a possible treatment for lymphedema. Lymphedema affects more than 200 million people in the world and currently has no approved pharmacological therapies. Mark Nicolls Amy Tian Xinguo Jiang Dongeon Kim